nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—CYP3A4—bone cancer	0.691	1	CbGaD
Clofazimine—ABCB11—Doxorubicin—bone cancer	0.163	0.59	CbGbCtD
Clofazimine—ABCB1—Cisplatin—bone cancer	0.0416	0.151	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—bone cancer	0.0279	0.101	CbGbCtD
Clofazimine—ABCB1—Methotrexate—bone cancer	0.027	0.0979	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—bone cancer	0.0167	0.0606	CbGbCtD
Clofazimine—Thromboembolism—Epirubicin—bone cancer	0.00124	0.038	CcSEcCtD
Clofazimine—Enteritis—Methotrexate—bone cancer	0.00124	0.0378	CcSEcCtD
Clofazimine—Thromboembolism—Doxorubicin—bone cancer	0.00115	0.0352	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—bone cancer	0.000784	0.0239	CcSEcCtD
Clofazimine—Body temperature increased—Carboplatin—bone cancer	0.000741	0.0226	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—bone cancer	0.000725	0.0222	CcSEcCtD
Clofazimine—Embolism—Methotrexate—bone cancer	0.000659	0.0201	CcSEcCtD
Clofazimine—Embolism—Epirubicin—bone cancer	0.000616	0.0188	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—bone cancer	0.00057	0.0174	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—bone cancer	0.000569	0.0174	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.000559	0.0171	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—bone cancer	0.000559	0.0171	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—bone cancer	0.000527	0.0161	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—bone cancer	0.000517	0.0158	CcSEcCtD
Clofazimine—Hypokalaemia—Cisplatin—bone cancer	0.000509	0.0155	CcSEcCtD
Clofazimine—Skin discolouration—Methotrexate—bone cancer	0.000468	0.0143	CcSEcCtD
Clofazimine—Skin discolouration—Epirubicin—bone cancer	0.000438	0.0134	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—bone cancer	0.000413	0.0126	CcSEcCtD
Clofazimine—Cystitis noninfective—Methotrexate—bone cancer	0.000413	0.0126	CcSEcCtD
Clofazimine—Cystitis—Methotrexate—bone cancer	0.000408	0.0125	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—bone cancer	0.000405	0.0124	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—bone cancer	0.000386	0.0118	CcSEcCtD
Clofazimine—Bladder pain—Methotrexate—bone cancer	0.000382	0.0117	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—bone cancer	0.000382	0.0117	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—bone cancer	0.000382	0.0117	CcSEcCtD
Clofazimine—Visual impairment—Cisplatin—bone cancer	0.000373	0.0114	CcSEcCtD
Clofazimine—Lymphadenopathy—Methotrexate—bone cancer	0.00036	0.011	CcSEcCtD
Clofazimine—Bladder pain—Epirubicin—bone cancer	0.000358	0.0109	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—bone cancer	0.000358	0.0109	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—bone cancer	0.000353	0.0108	CcSEcCtD
Clofazimine—Lymphadenopathy—Epirubicin—bone cancer	0.000337	0.0103	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—bone cancer	0.000331	0.0101	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000325	0.00993	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—bone cancer	0.000311	0.00951	CcSEcCtD
Clofazimine—Anaemia—Cisplatin—bone cancer	0.000311	0.00951	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000304	0.00929	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000287	0.00877	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000282	0.0086	CcSEcCtD
Clofazimine—Oedema—Cisplatin—bone cancer	0.000275	0.00839	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000266	0.00811	CcSEcCtD
Clofazimine—Eosinophilia—Methotrexate—bone cancer	0.000263	0.00802	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—bone cancer	0.000262	0.00801	CcSEcCtD
Clofazimine—Anorexia—Cisplatin—bone cancer	0.000262	0.008	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—bone cancer	0.000261	0.00798	CcSEcCtD
Clofazimine—Eosinophilia—Epirubicin—bone cancer	0.000246	0.00751	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—bone cancer	0.000243	0.00741	CcSEcCtD
Clofazimine—Photosensitivity reaction—Methotrexate—bone cancer	0.000242	0.00739	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—bone cancer	0.000242	0.00739	CcSEcCtD
Clofazimine—Decreased appetite—Cisplatin—bone cancer	0.000239	0.0073	CcSEcCtD
Clofazimine—Drowsiness—Methotrexate—bone cancer	0.000236	0.00722	CcSEcCtD
Clofazimine—Depression—Methotrexate—bone cancer	0.000236	0.0072	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—bone cancer	0.000227	0.00694	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—bone cancer	0.000227	0.00692	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—bone cancer	0.000225	0.00686	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—bone cancer	0.000224	0.00684	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—bone cancer	0.000221	0.00676	CcSEcCtD
Clofazimine—Body temperature increased—Cisplatin—bone cancer	0.000217	0.00664	CcSEcCtD
Clofazimine—Jaundice—Epirubicin—bone cancer	0.000216	0.00659	CcSEcCtD
Clofazimine—Hepatitis—Methotrexate—bone cancer	0.000212	0.00648	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00021	0.0064	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—bone cancer	0.000208	0.00635	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—bone cancer	0.000207	0.00633	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—bone cancer	0.000205	0.00625	CcSEcCtD
Clofazimine—Visual impairment—Methotrexate—bone cancer	0.000205	0.00625	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—bone cancer	0.0002	0.0061	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—bone cancer	0.000199	0.00607	CcSEcCtD
Clofazimine—Asthenia—Cisplatin—bone cancer	0.000197	0.00602	CcSEcCtD
Clofazimine—Visual impairment—Epirubicin—bone cancer	0.000191	0.00585	CcSEcCtD
Clofazimine—Diarrhoea—Cisplatin—bone cancer	0.000188	0.00574	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—bone cancer	0.000184	0.00561	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—bone cancer	0.000177	0.00541	CcSEcCtD
Clofazimine—Vomiting—Cisplatin—bone cancer	0.000175	0.00534	CcSEcCtD
Clofazimine—Rash—Cisplatin—bone cancer	0.000173	0.00529	CcSEcCtD
Clofazimine—Dermatitis—Cisplatin—bone cancer	0.000173	0.00529	CcSEcCtD
Clofazimine—Anaemia—Methotrexate—bone cancer	0.000171	0.00522	CcSEcCtD
Clofazimine—Nausea—Cisplatin—bone cancer	0.000163	0.00499	CcSEcCtD
Clofazimine—Anaemia—Epirubicin—bone cancer	0.00016	0.00488	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—bone cancer	0.000148	0.00452	CcSEcCtD
Clofazimine—Anorexia—Methotrexate—bone cancer	0.000144	0.00439	CcSEcCtD
Clofazimine—Oedema—Epirubicin—bone cancer	0.000141	0.00431	CcSEcCtD
Clofazimine—Anorexia—Epirubicin—bone cancer	0.000135	0.00411	CcSEcCtD
Clofazimine—Somnolence—Methotrexate—bone cancer	0.000134	0.00409	CcSEcCtD
Clofazimine—Decreased appetite—Methotrexate—bone cancer	0.000131	0.004	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—bone cancer	0.000131	0.00399	CcSEcCtD
Clofazimine—Fatigue—Methotrexate—bone cancer	0.00013	0.00397	CcSEcCtD
Clofazimine—Somnolence—Epirubicin—bone cancer	0.000125	0.00383	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—bone cancer	0.000124	0.0038	CcSEcCtD
Clofazimine—Decreased appetite—Epirubicin—bone cancer	0.000123	0.00375	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—bone cancer	0.000122	0.00372	CcSEcCtD
Clofazimine—Constipation—Epirubicin—bone cancer	0.000121	0.00369	CcSEcCtD
Clofazimine—Body temperature increased—Methotrexate—bone cancer	0.000119	0.00364	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—bone cancer	0.000116	0.00355	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—bone cancer	0.000114	0.00347	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—bone cancer	0.000113	0.00344	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—bone cancer	0.000112	0.00341	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—bone cancer	0.000112	0.00341	CcSEcCtD
Clofazimine—Asthenia—Methotrexate—bone cancer	0.000108	0.0033	CcSEcCtD
Clofazimine—Pruritus—Methotrexate—bone cancer	0.000107	0.00326	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—bone cancer	0.000103	0.00315	CcSEcCtD
Clofazimine—Diarrhoea—Methotrexate—bone cancer	0.000103	0.00315	CcSEcCtD
Clofazimine—Asthenia—Epirubicin—bone cancer	0.000101	0.00309	CcSEcCtD
Clofazimine—Pruritus—Epirubicin—bone cancer	9.99e-05	0.00305	CcSEcCtD
Clofazimine—Dizziness—Methotrexate—bone cancer	9.97e-05	0.00305	CcSEcCtD
Clofazimine—Diarrhoea—Epirubicin—bone cancer	9.66e-05	0.00295	CcSEcCtD
Clofazimine—Vomiting—Methotrexate—bone cancer	9.59e-05	0.00293	CcSEcCtD
Clofazimine—Rash—Methotrexate—bone cancer	9.51e-05	0.0029	CcSEcCtD
Clofazimine—Dermatitis—Methotrexate—bone cancer	9.5e-05	0.0029	CcSEcCtD
Clofazimine—Headache—Methotrexate—bone cancer	9.45e-05	0.00289	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—bone cancer	9.37e-05	0.00286	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—bone cancer	9.33e-05	0.00285	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—bone cancer	9.24e-05	0.00282	CcSEcCtD
Clofazimine—Vomiting—Epirubicin—bone cancer	8.97e-05	0.00274	CcSEcCtD
Clofazimine—Nausea—Methotrexate—bone cancer	8.96e-05	0.00274	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—bone cancer	8.94e-05	0.00273	CcSEcCtD
Clofazimine—Rash—Epirubicin—bone cancer	8.9e-05	0.00272	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—bone cancer	8.89e-05	0.00272	CcSEcCtD
Clofazimine—Headache—Epirubicin—bone cancer	8.84e-05	0.0027	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—bone cancer	8.64e-05	0.00264	CcSEcCtD
Clofazimine—Nausea—Epirubicin—bone cancer	8.38e-05	0.00256	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—bone cancer	8.3e-05	0.00254	CcSEcCtD
Clofazimine—Rash—Doxorubicin—bone cancer	8.23e-05	0.00251	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—bone cancer	8.23e-05	0.00251	CcSEcCtD
Clofazimine—Headache—Doxorubicin—bone cancer	8.18e-05	0.0025	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—bone cancer	7.76e-05	0.00237	CcSEcCtD
